Potential inhibition of SARS-CoV-2 infection and its mutation with the novel geldanamycin analogue: Ignaciomycin-Reference-Cited by-同舟云学术

Potential inhibition of SARS-CoV-2 infection and its mutation with the novel geldanamycin analogue: Ignaciomycin

Published:2024-02 Issue:2 Volume:17 Page:105493
ISSN:1878-5352
Container-title:Arabian Journal of Chemistry
language:en
Short-container-title:Arabian Journal of Chemistry

Author:

Stalin Antony,Saravana Kumar Pachaiyappan,Senthamarai Kannan Balakrishnan,Saravanan Rajamanikam,Ignacimuthu Savarimuthu,Zou Quan

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

General Chemical Engineering,General Chemistry

Reference68 articles.

1. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening;Abian;Int J Biol Macromol.,2020

2. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers;Abraham;SoftwareX.,2015

3. Bioactive potentiality of secondary metabolites from endophytic bacteria against SARS-COV-2: An in-silico approach;Akter;PLoS One.,2022

4. Geranii Herba as a Potential Inhibitor of SARS-CoV-2 Main 3CL(pro), Spike RBD, and Regulation of Unfolded Protein Response: An In Silico Approach;Arokiyaraj;Antibiotics (basel).,2020

5. COVID-19 Biomarkers Recognition & Classification Using Intelligent Systems;Bajo-Morales;Current Bioinformatics.,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico and ADMET molecular analysis targeted to discover novel anti-inflammatory drug candidates as COX-2 inhibitors from specific metabolites of Diospyros batokana (Ebenaceae);Biochemistry and Biophysics Reports;2024-09

2. Harnessing immunity: Immunomodulatory therapies in COVID-19;World Journal of Virology;2024-06-25